The National Pancreas Foundation held the first-ever externally-led Patient-Focused Drug Development (EL-PFDD) meeting on pancreatitis for our pancreatitis community and the U.S. Food and Drug Administration (FDA). We want to hear from pancreatitis patients/caregivers of patients! If you attended, whether in-person or via webcast, or couldn't make it, please take a moment to complete the post-meeting survey to add to the Voice of the Patient Report that will be sent to the FDA. Survey will close June 10th.
